Sujuan Sun

931 total citations
46 papers, 754 citations indexed

About

Sujuan Sun is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Sujuan Sun has authored 46 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Surgery. Recurrent topics in Sujuan Sun's work include Pancreatic function and diabetes (13 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Treatment and Management (7 papers). Sujuan Sun is often cited by papers focused on Pancreatic function and diabetes (13 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Treatment and Management (7 papers). Sujuan Sun collaborates with scholars based in China, United Kingdom and Russia. Sujuan Sun's co-authors include Zhufang Shen, Shuainan Liu, Yi Huan, Caina Li, Quan Liu, Lei Lei, Quan Liu, Mingzhi Xie, Quan Liu and Nan Guo and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Sujuan Sun

43 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sujuan Sun China 18 379 229 177 144 117 46 754
Elango Bhakkiyalakshmi India 16 478 1.3× 223 1.0× 120 0.7× 133 0.9× 101 0.9× 20 946
Amy K. Rines United States 9 657 1.7× 293 1.3× 231 1.3× 260 1.8× 161 1.4× 10 1.1k
Leonardo del Valle‐Mondragón Mexico 21 350 0.9× 179 0.8× 93 0.5× 221 1.5× 97 0.8× 83 1.0k
Søs Skovsø Canada 9 288 0.8× 280 1.2× 186 1.1× 231 1.6× 94 0.8× 13 790
Hongwei Si China 11 220 0.6× 258 1.1× 98 0.6× 103 0.7× 94 0.8× 29 831
Masumi Kamiyama Japan 16 394 1.0× 205 0.9× 86 0.5× 104 0.7× 74 0.6× 25 1.2k
Qingwen Qian United States 16 501 1.3× 131 0.6× 222 1.3× 128 0.9× 201 1.7× 26 972
Leida Maria Botion Brazil 17 356 0.9× 258 1.1× 121 0.7× 403 2.8× 215 1.8× 41 1.1k
Catherine Oiry France 15 308 0.8× 250 1.1× 165 0.9× 183 1.3× 81 0.7× 33 922
Maha A. Alamin Saudi Arabia 16 218 0.6× 160 0.7× 73 0.4× 81 0.6× 70 0.6× 30 709

Countries citing papers authored by Sujuan Sun

Since Specialization
Citations

This map shows the geographic impact of Sujuan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujuan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujuan Sun more than expected).

Fields of papers citing papers by Sujuan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujuan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujuan Sun. The network helps show where Sujuan Sun may publish in the future.

Co-authorship network of co-authors of Sujuan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Sujuan Sun. A scholar is included among the top collaborators of Sujuan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujuan Sun. Sujuan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Haoran, Yan Xie, Shan Hu, et al.. (2025). HBV upregulates TNNT1 expression through PI3K/AKT/mTOR-c-Myc axis, which in turn induces EMT and liver fibrosis in mice. Cellular Signalling. 134. 111899–111899.
2.
Chen, Yajing, Juan Liu, Xueping Zhao, et al.. (2024). A cross-sectional study on post-stroke depression and the quality of life. BMC Psychology. 12(1). 646–646. 3 indexed citations
3.
Huan, Yi, Shuainan Liu, Caina Li, et al.. (2022). Diphenyl Diselenide Alleviates Tert-Butyl Hydrogen Peroxide-Induced Oxidative Stress and Lipopolysaccharide-Induced Inflammation in Rat Glomerular Mesangial Cells. International Journal of Molecular Sciences. 23(19). 11215–11215. 12 indexed citations
4.
Gao, Wenjuan, et al.. (2022). An Evidence-Based Nursing Intervention Decreases Anxiety, Depression, Sleep Quality and Somatic Symptoms of Patients with Acute Ischemic Stroke. Neuropsychiatric Disease and Treatment. Volume 18. 2443–2451. 10 indexed citations
5.
Wang, Xing, Caina Li, Yi Huan, et al.. (2021). Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation. Chemico-Biological Interactions. 338. 109427–109427. 20 indexed citations
6.
Li, Caina, Xing Wang, Sujuan Sun, et al.. (2020). Effects of a ready‐to‐eat cereal formula powder on glucose metabolism, inflammation, and gut microbiota in diabetic db/db mice. Food Science & Nutrition. 8(8). 4523–4533. 6 indexed citations
7.
Cao, Hui, Caina Li, Lei Lei, et al.. (2020). Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice. Frontiers in Pharmacology. 11. 578943–578943. 36 indexed citations
8.
Wang, Xing, Lei Lei, Minzhi Liu, et al.. (2019). Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice. Phytotherapy Research. 34(5). 1166–1174. 49 indexed citations
9.
10.
Guo, Nan, Caina Li, Quan Liu, et al.. (2018). Maltol, a food flavor enhancer, attenuates diabetic peripheral neuropathy in streptozotocin-induced diabetic rats. Food & Function. 9(12). 6287–6297. 29 indexed citations
11.
Huan, Yi, Qian Jiang, Gang Li, et al.. (2017). The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo. Scientific Reports. 7(1). 4351–4351. 28 indexed citations
12.
Liu, Quan, Shuainan Liu, Sujuan Sun, et al.. (2017). Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KKAy mice. Acta Pharmaceutica Sinica B. 7(4). 461–469. 37 indexed citations
13.
Sun, Sujuan, et al.. (2015). [Determination of serum acetaminophen based on the diazo reaction and its application in the evaluation of gastric emptying].. PubMed. 50(5). 560–4. 2 indexed citations
14.
Lei, Lei, Quan Liu, Shuainan Liu, et al.. (2015). Antidiabetic potential of a novel dual-target activator of glucokinase and peroxisome proliferator activated receptor-γ. Metabolism. 64(10). 1250–1261. 22 indexed citations
15.
Liu, Shuainan, Yi Huan, Quan Liu, et al.. (2013). Long-term treatment with EXf, a peptide analog of Exendin-4, improves β-cell function and survival in diabetic KKAy mice. Peptides. 40. 123–132. 12 indexed citations
17.
Li, Caina, Yi Huan, Ning Shen, et al.. (2010). A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect. Biochemical and Biophysical Research Communications. 400(4). 563–568. 11 indexed citations
18.
Zhang, Ning, Yi Huan, Hui Huang, et al.. (2009). Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate. Acta Pharmacologica Sinica. 31(1). 35–42. 29 indexed citations
19.
Li, Pingping, Shan Song, Zhiqiang Ning, et al.. (2006). The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. British Journal of Pharmacology. 148(5). 610–618. 58 indexed citations
20.
Ding, Shi-Ying, et al.. (2005). Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Acta Pharmacologica Sinica. 26(5). 575–580. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026